Health Chi-Tech
Health Chi-Tech
In the high-stakes environment of the operating room, effective hemorrhage control is the cornerstone of surgical success. As a leading Custom OEM Hemostatic Agents Manufacturer, we understand that "one size fits all" no longer applies to surgical hemostasis. Modern medical practice demands specialized agents that integrate seamlessly with the patient's physiological clotting cascade while minimizing inflammatory responses.
Current research in bio-materials has shifted the focus from passive mechanical barriers to "smart" hemostatic agents. Our R&D department focuses on Information Gain through the development of oxidized regenerated cellulose (ORC), collagen-based sponges, and fibrin sealants that offer superior bio-absorption rates and localized antibacterial properties.
Global procurement teams often face the challenge of finding agents that meet specific surgical niches—whether it's neurosurgery requiring rapid absorption or trauma surgery needing high-pressure resistance. Our OEM services allow for:
The China-based manufacturing ecosystem provides a unique competitive edge for global medical suppliers. Our facility, established in 2005, leverages two decades of industrial maturity to offer:
From raw material synthesis to ETO sterilization, our 4 production lines ensure 100% traceability and quality control.
Economies of scale allow us to provide premium medical grade hemostatic agents at a price point that supports healthcare accessibility.
With 21 years of export experience, we navigate complex international shipping regulations to ensure timely delivery to North America, Europe, and beyond.
In the medical device industry, Experience, Expertise, Authoritativeness, and Trust (E-E-A-T) are not just SEO metrics; they are life-saving requirements. Our factory's 21-year history is a testament to our reliability in the global market.
Navigating the MDR (Medical Device Regulation) in Europe or FDA 510(k) in the USA requires deep technical expertise. We provide our global partners with comprehensive technical files, clinical evaluation reports (CERs), and localized documentation support to accelerate market entry.
The industry is moving toward bio-resorbable nanotechnology. We are investing in R&D for nanofiber-based hemostats that not only stop bleeding in seconds but also deliver localized therapeutic agents to accelerate tissue regeneration. This "Dual-Action" approach is the next frontier for Custom OEM Hemostatic Agents.
High-speed hemostatic gauze for field use, designed for massive arterial bleeding control.
Specialized bone wax and gelatin sponges designed for use with spinal fixation and joint replacement systems.
Small-format absorbable plugs optimized for socket preservation and oral surgical procedures.
